Boston Scientific device wins approval in Europe

Boston Scientific Corp., the second-biggest maker of heart devices, received marketing approval in Europe for its implantable Livian, used to monitor heartbeats and deliver electrical jolts to improve pumping ability. The Livian device, not available for sale in the United States, is under review by the Food and Drug Administration, Natick-based Boston Scientific said. The device is used to treat patients with heart failure. The approval is the first for Boston Scientific of one of its cardiac rhythm devices for heart failure. (Bloomberg)

Millennium Pharmaceuticals will receive a $40 million milestone payment from Ortho Biotech Products for reaching a sales goal for its multiple myeloma treatment. The Cambridge-based biotechnology company said its Velcade injection hit an unspecified "material sales milestone" outside the United States. The drug is a treatment for cancer affecting white blood cells and bone marrow. (AP)

American Tower Corp. sued a former Goldman Sachs executive who heads a rival wireless tower operator, alleging he impersonated the Boston company's chief executive while e-mailing a negative article about the company to two large investors. According to the complaint filed in US District Court in Manhattan, Jide Zeitlin contacted a Money magazine reporter and provided her with negative information about American Tower. Zeitlin, the founder of private equity firm Keffi Group Ltd., then used an e-mail tool on CNN.com to send a copy of the Money report to two of American Tower's large investors, the company alleged in the complaint. The outgoing e-mail address made it seem like the sender was American Tower chief executive James Taiclet, it said. (Reuters)

Remington Arms Co. plans to buy Marlin Firearms Co. for about $41.7 million, Remington said in a filing with the Securities and Exchange Commission. North Carolina-based Remington will make the purchase by buying the shares of North Haven, Conn.-based Marlin. Remington, which was acquired by private investment firm Cerberus Capital Management in April, will add Marlin's long guns, including lever action rifles. (AP)

Macy's Inc., the second-largest US department store chain, is closing nine stores with inadequate sales and said it will eliminate 899 jobs. None of the closings is in New England. The company will operate 815 Macy's after the closings. The Cincinnati company opened 10 stores and one furniture gallery this year. (Bloomberg)

The pay of Ralph J. Roberts, 87, the founder of Comcast Corp., will keep going to his beneficiaries for five years after his death under a new agreement. Roberts' new salary agreement takes effect on Jan. 1, according to a document the company filed with the Securities and Exchange Commission. The pact succeeds Roberts' current compensation deal, which expires next week. Roberts, whose son Brian now heads the company, sits on the board of directors and is chairman of its executive and finance committee. In 2006, Roberts was paid a salary of $1.8 million. His full 2007 salary and benefits will be disclosed when the company files its proxy statement next year. (AP)

Dubai World, the investment arm of the Dubai government, raised its stake in MGM Mirage Inc. to 6.5 percent by making a purchase through Kirk Kerkorian's charity, according to a filing with the Securities and Exchange Commission. Cayman LP, an investment group for the Dubai government, bought 5 million shares of the casino operator from the Lincy Foundation on Monday for $424 million, or $84.80 per share, the filing said. (AP)